How the US drug safety system should be changed

被引：75
作者：
Strom, BL [1 ]
机构：
[1] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 17期
关键词：
D O I：
10.1001/jama.295.17.2072
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2072 / 2075
页数：4
相关论文
共 19 条
  • [1] DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE
    BAKKE, OM
    MANOCCHIA, M
    DEABAJO, F
    KAITIN, KI
    LASAGNA, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) : 108 - 117
  • [2] The need for a national infrastructure to improve the rational use of therapeutics
    Califf, RM
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (04) : 319 - 327
  • [3] Gelfand JM, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P337
  • [4] REYES-SYNDROME AND MEDICATION USE
    HALPIN, TJ
    HOLTZHAUER, FJ
    CAMPBELL, RJ
    HALL, LJ
    CORREAVILLASENOR, A
    LANESE, R
    RICE, J
    HURWITZ, ES
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (06): : 687 - 691
  • [5] Disproportionality analyses of spontaneous reports
    Hennessy, S
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (08) : 503 - 504
  • [6] Hennessy S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P281
  • [7] HOLMES OW, 1861, WORKS, V9, P185
  • [8] Joint Commission on Prescription Drug Use, 1980, FIN REP
  • [9] Managing the risks of therapeutic products: proceedings of a workshop
    Kramer, JM
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (09) : 619 - 628
  • [10] Timing of new black box warnings and withdrawals for prescription medications
    Lasser, KE
    Allen, PD
    Woolhandler, SJ
    Himmelstein, DU
    Wolfe, SN
    Bor, DH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17): : 2215 - 2220
12